Denmark Cuts Johnson & Johnson From Covid-19 Vaccine Program (1)

May 3, 2021, 2:39 PM UTC

Denmark won’t use Johnson & Johnson’s Covid-19 vaccine in its immunization program, because the benefits don’t outweigh the risk of blood clots, according to the country’s health authority.

The suspension comes less than a month after Denmark became the first European Union member to drop AstraZeneca Plc for similar reasons. Monday’s decision was first reported by the BT newspaper.

The Danish Health Authority said it took into account the current situation in Denmark where the virus is under relative control and most unvaccinated people are young and healthy.

Denmark had pre-ordered about 7 million vaccine shots from J&J, more ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.